Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

1.1K
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
1.1K
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

545
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
545
Disturbances in Heart Rhythm01:29

Disturbances in Heart Rhythm

3.4K
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
3.4K
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

711
Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
711
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers01:24

Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers

2.1K
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
2.1K
Dysrhythmias V: Evaluating Dysrhythmias01:30

Dysrhythmias V: Evaluating Dysrhythmias

423
Dysrhythmias, also known as arrhythmias, are disturbances in the heart's rhythm that range from benign to life-threatening. A thorough evaluation is crucial for appropriate management and involves a comprehensive medical history, physical examination, and various diagnostic tests.Medical HistorySymptoms: Collect detailed information on palpitations, dizziness, syncope, chest pain, and fatigue. Note their onset, frequency, and triggers.Previous Cardiac Issues: Document any history of heart...
423

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

From the Emergency Department, Directly to Ablation of Atrial Fibrillation: Rationale and Design of the EMERGE Cryo Study.

CJC open·2026
Same author

Ventricular dispersion and repolarization in Marfan syndrome: A clinical analysis.

Heart rhythm O2·2025
Same author

Response to: implantable cardiac devices in cardiac sarcoidosis-it's about preventing the unforeseeable.

European heart journal. Case reports·2023
Same author

Intermittent complete atrioventricular block in a 20-year-old woman with cardiac sarcoidosis: a case report.

European heart journal. Case reports·2022
Same author

Genetic and Clinical Predictors of Left Atrial Thrombus: A Single Center Case-Control Study.

Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·2021
Same author

Supervised Obesity Reduction Trial for AF ablation patients: results from the SORT-AF trial.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology·2021

関連する実験動画

Updated: Mar 2, 2026

Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation
08:56

Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation

Published on: September 24, 2021

3.2K

[リズムロジーにおける緊急薬物療法]

Boris A Hoffmann1

  • 1Klinik für Kardiologie - Rhythmologie, Asklepios Klinikum Harburg, Eißendorfer Pferdeweg 52, 21075, Hamburg, Deutschland. bo.hoffmann@asklepios.com.

Herzschrittmachertherapie & Elektrophysiologie
|March 1, 2026
PubMed
まとめ
この要約は機械生成です。

心室頻脈性不整脈を含む急性心不整脈には、迅速な薬物療法が不可欠です。確立された特定の抗不整脈薬は、緊急心臓電気生理学における血行動態不安定性と死亡率の予防に不可欠です。

キーワード:
抗不整脈薬心房細動徐脈上室頻拍心室頻拍

さらに関連する動画

Methods for ECG Evaluation of Indicators of Cardiac Risk, and Susceptibility to Aconitine-induced Arrhythmias in Rats Following Status Epilepticus
08:28

Methods for ECG Evaluation of Indicators of Cardiac Risk, and Susceptibility to Aconitine-induced Arrhythmias in Rats Following Status Epilepticus

Published on: April 5, 2011

18.2K
Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine
10:05

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine

Published on: July 7, 2016

8.9K

関連する実験動画

Last Updated: Mar 2, 2026

Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation
08:56

Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation

Published on: September 24, 2021

3.2K
Methods for ECG Evaluation of Indicators of Cardiac Risk, and Susceptibility to Aconitine-induced Arrhythmias in Rats Following Status Epilepticus
08:28

Methods for ECG Evaluation of Indicators of Cardiac Risk, and Susceptibility to Aconitine-induced Arrhythmias in Rats Following Status Epilepticus

Published on: April 5, 2011

18.2K
Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine
10:05

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine

Published on: July 7, 2016

8.9K

科学分野:

  • 臨床心臓電気生理学
  • 救急医学
  • 薬理学

背景:

  • 急性心不整脈は一般的であり、予後的に重要な緊急事態です。
  • 不整脈は、徐脈や上室頻拍から、生命を脅かす心室頻脈性不整脈や電気的嵐まで多岐にわたります。
  • 血行動態不安定性と死亡率を防ぐためには、迅速で構造化された、ガイドラインに基づいた薬物療法が不可欠です。

研究 の 目的:

  • 急性心不整脈の必須薬物療法をレビューすること。
  • 緊急時における確立された抗不整脈薬の重要性を強調すること。
  • 複雑な心室不整脈における特定の薬剤の役割を議論すること。

主な方法:

  • 急性不整脈管理に関する現在の臨床実践と文献のレビュー。
  • 不整脈の種類、血行動態、および患者因子に基づく薬剤選択基準の分析。
  • 確立された、およびあまり一般的でない抗不整脈薬の議論。

主要な成果:

  • 緊急薬の選択は、不整脈、血行動態、および患者因子によって異なります。
  • 古典的な抗不整脈薬、房室結節作動薬、β遮断薬、カルシウム拮抗薬、アデノシン、配糖体、およびカテコールアミンが鍵となります。
  • 新しい承認がないため、確立された薬剤は依然として重要であり、プロカインアミドとメキシレチンは複雑な心室不整脈に考慮されます。

結論:

  • 急性心不整脈の効果的な管理は、適切な薬物療法にかかっています。
  • 確立された抗不整脈薬は、緊急治療の礎です。
  • 特殊な薬剤は、難治性または複雑な心室不整脈にとって極めて重要である可能性があります。